Department of Health and Human Services August 14, 2024 – Federal Register Recent Federal Regulation Documents
Results 1 - 15 of 15
Notice of Purchased/Referred Care Delivery Area Redesignation for the Confederated Tribes of the Grand Ronde Community of Oregon
Notice is hereby given that the Indian Health Service (IHS) has decided to expand the geographic boundaries of the Purchased/ Referred Care Delivery Area (PRCDA) for the Confederated Tribes of the Grand Ronde Community of Oregon (CTGR) to include the county of Clackamas in the State of Oregon. The current PRCDA for the CTGR includes the Oregon counties of Washington, Polk, Yamhill, Marion, Multnomah, and Tillamook. The sole purpose of this expansion is to authorize additional CTGR members and beneficiaries to receive purchased/referred care (PRC) services.
Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a virtual meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The meeting will be available to the public through the live stream on hhs.gov/live. Individuals are encouraged to provide written public comment, submitted via email to CARB@hhs.gov. Registration information is available on the PACCARB website https://www.hhs.gov/paccarb and should be completed by August 27, 2024, for the August 29, 2024, virtual Public Meeting. Additional information about registering for the meeting can be obtained at https://www.hhs.gov/paccarb on the Upcoming Meetings page.
International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Hexahydrocannabinol; N-Pyrrolidino Protonitazene (Protonitazepyne); N-Pyrrolidino Metonitazene (Metonitazepyne); N-Piperidinyl Etonitazene (Etonitazepipne); N-Desethyl-isotonitazene; 3-Hydroxy-phencyclidine; N-Ethylheptedrone; Carisoprodol; Request for Comments
The Food and Drug Administration (FDA or Agency) is inviting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of eight drug substances. These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drug substances. This notice requesting comments is required by the Controlled Substances Act (CSA).
Submission for Office of Management and Budget Review; Behavioral Interventions To Advance Self-Sufficiency-Next Generation (BIAS-NG) (Office of Management and Budget #0970-0502)
The Office of Planning, Research, and Evaluation (OPRE) in the Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS) requests Office of Management and Budget (OMB) approval to modify and extend the approval of the ACF Behavioral Interventions to Advance Self-Sufficiency-Next Generation (BIAS-NG) Project Overarching Generic (OMB #: 0970-0502; Expiration date: 8/31/2025.) Under this overarching clearance, ACF collects data as part of rapid cycle testing and evaluation, to inform the design of interventions informed by behavioral science and to better understand the mechanisms and effects of such interventions. Interventions have been and will continue to be developed in the program area domains of Temporary Assistance for Needy Families (TANF), child welfare, and Early Head Start/Head Start (EHS/ HS). This revision would also allow for collection of data in the child care program area, and would extend the approval of the overarching generic. These interventions are intended to improve outcomes for participants in these programs.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.